Awiqli

Weekly insulin icodec

70 units once weekly

Awiqli® is a long-acting basal insulin known as insulin icodec, recently approved in Canada. It is designed for once-weekly dosing, offering a more convenient alternative to daily long-acting insulins for adults with type 2 diabetes. Awiqli helps maintain steady blood sugar levels over the course of a full week, improving adherence and simplifying diabetes management.

Who Awiqli is For

Awiqli is indicated for adults with type 2 diabetes who require basal insulin to control blood sugar. It can be part of a broader diabetes care plan, alongside oral medications or GLP-1 therapies, depending on individual needs.